Treatment patterns, risk factor control and functional capacity in patients with cardiovascular and chronic kidney disease in the cardiac rehabilitation setting

被引:13
|
作者
Voeller, Heinz [1 ,2 ]
Gitt, Anselm [3 ]
Jannowitz, Christina [4 ]
Karoff, Marthin [5 ]
Karmann, Barbara [4 ]
Pittrow, David [6 ]
Reibis, Rona [1 ,7 ]
Hildemann, Steven [4 ,8 ]
机构
[1] Klin See, Dept Cardiol, Rudersdorf, Germany
[2] Univ Potsdam, Rehabil Res Ctr, D-14469 Potsdam, Germany
[3] Heidelberg Univ, Inst Herzinfarktforsch, D-69115 Heidelberg, Germany
[4] MSD Sharp & Dohme GmbH, Med Affairs & Klin Forsch, Haar, Germany
[5] Klin Univ Witten Herdecke, Klin Konigsfeld Deutsch Rentenversicherung Westfa, Witten, Germany
[6] Tech Univ Dresden, Fac Med, Inst Clin Pharmacol, Dresden, Germany
[7] Cardiol Outpatient Clin, Potsdam, Germany
[8] Univ Herzzentrum Freiburg Bad Krozingen, Klin Kardiol & Angiol 1, Bad Krozingen, Germany
关键词
Cardiac rehabilitation; registry; chronic kidney disease; glomerular filtration rate; dyslipidemia; control rates; risk factor; lipids; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; RENAL-FUNCTION; PREVALENCE; HEART; ASSOCIATION; CHOLESTEROL; EXERCISE;
D O I
10.1177/2047487313482285
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Chronic kidney disease (CKD) is a frequent comorbidity among elderly patients and those with cardiovascular disease. CKD carries prognostic relevance. We aimed to describe patient characteristics, risk factor management and control status of patients in cardiac rehabilitation (CR), differentiated by presence or absence of CKD. Design and methods: Data from 92,071 inpatients with adequate information to calculate glomerular filtration rate (GFR) based on the Cockcroft-Gault formula were analyzed at the beginning and the end of a 3-week CR stay. CKD was defined as estimated GFR <60 ml/min/1.73 m(2). Results: Compared with non-CKD patients, CKD patients were significantly older (72.0 versus 58.0 years) and more often had diabetes mellitus, arterial hypertension, and atherothrombotic manifestations (previous stroke, peripheral arterial disease), but fewer were current or previous smokers had a CHD family history. Exercise capacity was much lower in CKD (59 vs. 92Watts). Fewer patients with CKD were treated with percutaneous coronary intervention (PCI), but more had coronary artery bypass graft (CABG) surgery. Patients with CKD compared with non-CKD less frequently received statins, acetylsalicylic acid (ASA), clopidogrel, beta blockers, and angiotensin converting enzyme (ACE) inhibitors, and more frequently received angiotensin receptor blockers, insulin and oral anticoagulants. In CKD, mean low density lipoprotein cholesterol (LDL-C), total cholesterol, and high density lipoprotein cholesterol (HDL-C) were slightly higher at baseline, while triglycerides were substantially lower. This lipid pattern did not change at the discharge visit, but overall control rates for all described parameters (with the exception of HDL-C) were improved substantially. At discharge, systolic blood pressure (BP) was higher in CKD (124 versus 121 mmHg) and diastolic BP was lower (72 versus 74 mmHg). At discharge, 68.7% of CKD versus 71.9% of non-CKD patients had LDL-C <100 mg/dl. Physical fitness on exercise testing improved substantially in both groups. When the Modification of Diet in Renal Disease (MDRD) formula was used for CKD classification, there was no clinically relevant change in these results. Conclusion: Within a short period of 3-4 weeks, CR led to substantial improvements in key risk factors such as lipid profile, blood pressure, and physical fitness for all patients, even if CKD was present.
引用
收藏
页码:1125 / 1133
页数:9
相关论文
共 50 条
  • [21] Sedentary behaviour in cardiovascular disease patients: risk factor identification and the impact of cardiac rehabilitation
    Van Bakel, B. M. A.
    Bakker, E. A.
    Aengevaeren, W. R. M.
    Meindersma, E. P.
    Snoek, J. A.
    Waskowsky, W. M.
    Van Kuijk, A. A.
    Jacobs, M. M. L. M.
    Hopman, M. T. E.
    Thijssen, D. H. J.
    Eijsvogels, T. M. H.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2871 - 2871
  • [22] OBESITY AS A RISK FACTOR FOR CHRONIC KIDNEY DISEASE PROGRESSION AND INCIDENT CARDIOVASCULAR EVENTS IN PATIENTS WITH PREVALENT CHRONIC KIDNEY DISEASE
    Barbieri, Diego
    Goicoechea, Marian
    Garcia-Prieto, Ana
    Verdalles, Ursula
    Perez De Jose, Ana
    Verde, Eduardo
    Hurtado, Esther
    Delgado, Andres
    Sanchez-Camara, Luis
    Luno, Jose
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [23] Diabetes, Cardiovascular Disease, and Cardiovascular Risk in Patients with Chronic Kidney Disease
    De Lima, Jose J. G.
    Gowdak, Luis Henrique W.
    David-Neto, Elias
    Bortolotto, Luiz A.
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (02) : 159 - 165
  • [24] Diabetes, Cardiovascular Disease, and Cardiovascular Risk in Patients with Chronic Kidney Disease
    Jose J. G. De Lima
    Luis Henrique W. Gowdak
    Elias David-Neto
    Luiz A. Bortolotto
    High Blood Pressure & Cardiovascular Prevention, 2021, 28 : 159 - 165
  • [25] Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients
    Rhee, Connie M.
    Brent, Gregory A.
    Kovesdy, Csaba P.
    Soldin, Offie P.
    Danh Nguyen
    Budoff, Matthew J.
    Brunelli, Steven M.
    Kalantar-Zadeh, Kamyar
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (05) : 724 - 737
  • [26] Outcomes in patients with chronic kidney disease undergoing cardiac rehabilitation
    Venkataraman, R
    Sanderson, B
    Bittner, V
    AMERICAN HEART JOURNAL, 2005, 150 (06) : 1140 - 1146
  • [27] CALCIUM/MAGNESIUM RATIO IN PATIENTS WITH DIABETES AND CHRONIC KIDNEY DISEASE: A RISK FACTOR FOR CARDIOVASCULAR DISEASE
    Borges, Henrique
    Afonso, Rita
    Marques, Roberto Calcas
    Jeronimo, Teresa
    Silva, Ana
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1172 - I1173
  • [28] RISK FACTORS FOR CARDIOVASCULAR DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Alpert, M. A.
    CARDIOLOGY, 2013, 125 : 339 - 339
  • [29] RISK FACTORS FOR CARDIOVASCULAR DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Alpert, M. A.
    CARDIOLOGY, 2014, 128 : 90 - 90
  • [30] CHRONIC KIDNEY DISEASE AS A RISK FACTOR FOR CARDIOVASCULAR EVENTS OR MORTALITY
    Bowman, K.
    Ble, A.
    Delgado, J.
    Melzer, D.
    GERONTOLOGIST, 2015, 55 : 25 - 25